Centrum Medyczne ENEL-MED S.A.

WSE:ENE Stock Report

Market Cap: zł562.8m

Centrum Medyczne ENEL-MED Valuation

Is ENE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ENE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ENE (PLN19.9) is trading below our estimate of fair value (PLN57.99)

Significantly Below Fair Value: ENE is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ENE?

Key metric: As ENE is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ENE. This is calculated by dividing ENE's market cap by their current earnings.
What is ENE's PE Ratio?
PE Ratio80.6x
Earningszł6.98m
Market Capzł562.78m

Price to Earnings Ratio vs Peers

How does ENE's PE Ratio compare to its peers?

The above table shows the PE ratio for ENE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average24.2x
EMC EMC Instytut Medyczny
36.6xn/azł436.9m
VOX Voxel
14.4x5.6%zł1.3b
NEU NEUCA
21.7x25.6%zł3.5b
M-CHAI Mahachai Hospital
23.9xn/a฿4.6b
ENE Centrum Medyczne ENEL-MED
80.6xn/azł562.8m

Price-To-Earnings vs Peers: ENE is expensive based on its Price-To-Earnings Ratio (80.6x) compared to the peer average (24.2x).

Price to Earnings Ratio vs Industry

How does ENE's PE Ratio compare vs other companies in the European Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
ENE 80.6xIndustry Avg. 18.5xNo. of Companies10PE01020304050+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ENE is expensive based on its Price-To-Earnings Ratio (80.6x) compared to the European Healthcare industry average (18.5x).

Price to Earnings Ratio vs Fair Ratio

What is ENE's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ENE PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio80.6x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ENE's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies